Petmed Express Inc  

(Public, NASDAQ:PETS)   Watch this stock  
Find more results for PETS
+0.03 (0.18%)
Nov 27 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 16.94 - 17.09
52 week 13.29 - 18.42
Open 17.01
Vol / Avg. 75,779.00/180,189.00
Mkt cap 344.81M
P/E 17.14
Div/yield 0.18/4.24
EPS 0.99
Shares 20.33M
Beta 1.12
Inst. own 90%
Jan 18, 2016
Q3 2015 Petmed Express Inc Earnings Release (Estimated) - 8:00AM EST - Add to calendar
Oct 19, 2015
Q2 2015 Petmed Express Inc Earnings Call
Oct 19, 2015
Q2 2015 Petmed Express Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '15) 2015
Net profit margin 7.94% 7.61%
Operating margin 12.50% 12.04%
EBITD margin - 13.07%
Return on average assets 19.86% 21.65%
Return on average equity 22.99% 23.97%
Employees 182 -
CDP Score - -


1441 SW 29th Ave
POMPANO BEACH, FL 33069-4820
United States - Map
+1-954-9794788 (Phone)
+1-800-6008285 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


PetMed Express, Inc. (PetMed Express), doing business as 1800PetMeds is a pet pharmacy. The Company markets prescription and non-prescription pet medications and other health products for dogs and cats, direct to the consumer. The Company offers a selection of products for dogs and cats. The Company's product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies. These products include brands of medication, such as Frontline Plus, K9 Advantix II, Advantage II, Heartgard Plus, Sentinel, Revolution and Rimadyl. It also offers for sale additional pet supplies on its Website, which are drop shipped to its customers by third party vendors. These pet supplies include food, beds, crates, stairs, strollers and other pet supplies. The Company's products included Non-Prescription Medications (Over the Counter (OTC)) and supplies, and Prescription Medications (Rx).

Officers and directors

Robert C. Schweitzer Independent Chairman of the Board
Age: 69
Bio & Compensation  - Reuters
Menderes Akdag President, Chief Executive Officer, Director
Age: 54
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Bruce S. Rosenbloom Chief Financial Officer, Treasurer
Age: 46
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Frank J. Formica Independent Director
Age: 70
Bio & Compensation  - Reuters
Gian M. Fulgoni Independent Director
Age: 67
Bio & Compensation  - Reuters
Ronald J. Korn Independent Director
Age: 75
Bio & Compensation  - Reuters